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Upper urinary tract calculi are common; however,  there is no recommended treatment selection for 
elderly patients.  Ureteroscopic holmium laser lithotripsy (URS lithotripsy) is minimally invasive,  and 
it provides a high stone-free rate (SFR) treatment for upper urinary tract calculi.  Here,  we retrospec-
tively evaluated the surgical outcomes of URS lithotripsy after dividing the 189 cases into 3 groups by 
patient age: the ʻ＜65 groupʼ (＜65 years old,  n＝108),  the ʻ65-74 groupʼ (65-74 years old,  n＝42),  and 
the ʻ 75 groupʼ ( 75 years old,  n＝39).  The patientsʼ characteristics,  stone status,  and perioperative 
outcomes were assessed.  The 65-74 group and the 75 group had a signiﬁcantly higher prevalence of 
hypertension compared to the＜65 group.  Compared to the＜65 group,  the 65-74 group had a signiﬁ-
cantly higher prevalence of hyperlipidemia,  and the 75 group had signiﬁcantly higher the American 
Society of Anesthesiologists (ASA) scores.  Despite these preoperative risk factors,  SFR and postop-
erative pyelonephritis in the 65-74 group and the 75 group were similar to those of the＜65 group.  In 
conclusion,  URS lithotripsy is the preferred treatment for upper urinary tract calculi,  even for elderly 
patients who have multiple preoperative risk factors.
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U pper urinary tract calculi are common,  with a peak lifetime incidence between the ages of 40 
and 70 years [1]; more than 20  of patients with 
upper urinary tract calculi are 60 years or older.  The 
treatment for urinary stones in elderly patients is 
controversial because of economic,  sociologic,  and 
physical factors.
　 During the past 20 years,  advances in ureteroscopy 
have provided great progress.  Ureteroscopic holmium 
laser lithotripsy (URS lithotripsy) is one of the most 
frequently recommended treatments for upper urinary 
tract calculi,  especially for those less than 20mm in 
diameter [2,  3].  URS lithotripsy is minimally inva-
sive and has a high stone-free rate (SFR) [4].
　 Upper urinary tract calculi are common among 
elderly patients (i.e.,  those 65 years old); ＞25  of 
patients admitted to a hospital for upper urinary tract 
calculi in the U.S.  are 65 years old,  with an increas-
ing ratio [5].  The number of elderly patients with 
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upper urinary tract calculi is also increasing in Japan 
[6].  There are many interventions for upper urinary 
tract calculi,  including extracorporeal shock wave 
lithotripsy (SWL),  transurethral exchange of ureteral 
stents,  URS lithotripsy,  percutaneous nephrolithot-
omy (PCNL),  and active surveillance [2,  3,  5].  
However,  there are no standardized treatments for 
elderly patients with upper urinary tract calculi.
　 We hypothesized that URS lithotripsy is one of the 
best treatments for upper urinary tract calculi in 
elderly patients.  Elderly patients are deﬁned as 65 
years old according to the deﬁnitions of the World 
Health Organization (WHO) (http://www.who.int/
healthinfo/survey/ageingdefnolder/en/, November,  
2015) and the Japanese government (http://www.
mhlw.go.jp/bunya/shakaihosho/iryouseido01/
taikou05.html,  November,  2015).  In the present study 
we analyzed our recent experiences with URS litho-
tripsy,  and we evaluated the eﬀectiveness and safety 
of URS lithotripsy for upper urinary tract calculi in 
elderly patients.
Materials and Methods
　 Study design. We retrospectively reviewed our 
registry of 252 patients who underwent URS litho-
tripsy between January 2011 and October 2014.  The 
inclusion criteria were: Non-contrast enhanced com-
puted tomography (NCCT) before stone analysis at our 
center (Abiko Toho Hospital),  minimum stone size of 
4mm,  and ﬁrst-time URS lithotripsy.  Cases that 
lacked an NCCT scan and those with staghorn calculi,  
more than one treatment using URS,  and those that 
were post-SWL were excluded (Fig.  1).  Of the 252 
cases,  63 patients were excluded; the remaining 189 
patients were eligible.  WHO deﬁnes people who are 
65 years or more as old people.  We ﬁrst divided these 
patients into the younger group (i.e.,  the ʻ＜65 group,ʼ 
less than 65 years old) and the older group ( 65 years 
old).  Subsequently,  according to the Japanese govern-
mentʼs deﬁnition,  we divided the older ( 65 group) 
patients into 2 groups: the elderly patients (i.e.,  the 
ʻ65-74 group,ʼ from 65 to 74 years old) and the very 
elderly patients (the ʻ 75 group,ʼ those who were 
aged 75 years or more).  We retrospectively com-
pared the surgical outcomes of URS lithotripsy among 
these 3 groups.  The Ethics Review Board of Abiko 
Toho Hospital approved this study.
　 Image data analysis. The NCCT stone proto-
col of was performed with a 16-detector row CT 
scanner (Activion 16,  Toshiba,  Japan) using identical 
tube voltage (120kVp),  rotation time (0.75sec),  and 
detectors rows (16).  The stone diameters were evalu-
ated with transverse NCCT.  The Hounsﬁeld units 
(HU) measured on the NCCT were 0.5mm2 for each 
region of interest (ROI) placed at 3 points in the core 
region of a stone.  The target elements were: stone 
size,  HU,  preoperative complicated pyelonephritis,  
unilateral ureteral catheters,  complete resolution of 
stones,  and postoperative pyelonephritis.  One urolo-
gist measured all radiological data,  and one anesthesi-
ologist reviewed the American Society of 
Anesthesiologists (ASA) score.
　 Operative technique. First,  we preoperatively 
evaluated the urinalysis results for all patients,  and 
we conﬁrmed that there were no urinary tract infec-
tions (UTI) at the time of surgery.  For patients 
without a UTI at our hospital,  intravenous preopera-
tive antimicrobials (ceftriaxone) were administered 
30min before starting the URS lithotripsy.  For 
patients with a preoperative UTI (pyuria and/or bac-
teriuria),  intravenous antimicrobials susceptible to 
pathogenic bacteria referring to the urine culture 
were started at least 1 day before surgery.  For the 
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First time URS, and not post-SWL
189 cases
Excluded (n = 30)
　　More than one case of URS, 12 cases
　　　　　Post SWL, 18 cases
Stone size: 4mm or more, and not staghorn calculi
219 cases
Excluded (n = 28)
　　　　　Less than 4mm, 21 cases
　　　　　Staghorn calculi, 7 cases
Investigated NCCT scan
247 cases
Excluded (n = 5)
　　　　Lack of NCCT scan, 5 cases
Underwent URS lithotripsy in Abiko Toho Hospital
January 2011 － October 2014
252 cases
Fig. 1　 Flow diagram of the patient enrollment.
URS lithotripsy,  the patient was placed in the lithot-
omy position and draped in a sterile fashion,  under 
general anesthesia.  The urethra and the bladder were 
observed systemically,  and the bilateral ureteral ori-
ﬁces were identiﬁed using a 22.5 Fr rigid urethrocys-
toscope (Cystoscopes,  Olympus,  Tokyo,  Japan).  A 
semi-rigid 6/7.5 Fr ureterorenoscope (Ultrathin,  
Richard Wolf,  Knittlingen,  Germany) was inserted 
into a ureter without a guide wire.  URS lithotripsy 
was performed for ﬁxed ureteral stones,  and movable 
ureteral stones were pushed up to the renal pelvis.  An 
initial guide wire was placed to the level of inspection,  
and a 12/14.4 Fr Flexor sheath (Cook Medical,  
Bloomington,  IN,  USA) was passed over the guide 
wire to the level of inspection.  The guide wire was 
then removed.  A 12 Fr digital ﬂexible ureteroscope 
(URF-V,  Olympus) was inserted into the renal pelvis.  
For patients with a narrow ureter,  a ﬂexible uretero-
scope (URF P-5,  Olympus) was used without an 
access sheath.  All calyces were observed systemati-
cally to conﬁrm stone location,  size,  and number.  
URS lithotripsy was performed using a Holmium-YAG 
laser IH102 (MM & NIIC,  Tokyo,  Japan) at settings 
of 0.5 J and 10Hz for less than 90min.  Intermittent 
irrigation was controlled manually at the lowest pres-
sure with a 50-ml syringe.  Active fragment retrieval 
was performed repeatedly as long as graspable frag-
ments remained,  using an NCircle® stone extractor 
(Cook Medical).  The laser lithotripsy was completed 
when the fragment size was＜3mm,  which was deﬁned 
as complete fragmentation,  or when complete extrac-
tion of the stone fragments was attained.  We placed a 
6 Fr ureteral stent in all cases at the end of surgery,  
in order to reduce urinary tract complications,  fol-
lowed by removal within 2 weeks.
　 Stone-free status. After the operation,  kidney-
ureter-bladder (KUB) radiography was performed on 
postoperative day (POD) 1,  at postoperative month 
(POM) 1,  and at POM 3.  Stone-free (SF) status was 
deﬁned as complete resolution of stones on ureteros-
copy or no detectable stones on KUB radiography 
until POM3.
　 Statistical analysis. Statistical analyses of the 
patient outcomes and the patientsʼ stone status were 
performed using IBM SPSS Statistics v.19.0 for 
Windows software package (IBM,  Chicago,  IL,  USA).  
To compare outcomes,  Pearsonʼs chi square test was 
used for categorical variables,  and a one-way analysis 
of variance was used for continuous variables.  Tukeyʼs 
honestly signiﬁcant diﬀerence test was performed for 
multiple comparisons.  We calculated the odds ratios 
(ORs) and their 95  conﬁdence intervals (95 CI) for 
postoperative pyelonephritis and SFR using univariate 
and multivariate analyses of the logistic regression 
model.  We deﬁned statistical signiﬁcance as p＜0.05.  
Not all data were available for every patient.  
Percentages were calculated and analyses were per-
formed on all available data.
Results
　 Of the 189 cases,  the＜65 group was 108 patients,  
the 65-74 group was 42 patients,  and the 75 group 
was 39 patients (Fig.  1,  Table 1).  Table 1 shows the 
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Table 1　 The patientsʼ characteristics
＜65 group 65-74 group 75 group
n＝108 n＝42 n＝39
Mean SD Mean SD Mean SD p
Age (years) 51.08 11.17 69.26 2.92 79.46 4.69 ＜0.001
Gender (n,  Male : Female) 73 : 35 24 : 18 19 : 20 0.095
BMI (kg/m2) 25.10 4.42 23.06 4.45 21.83 3.79 ＜0.001
ASA score 1.58 0.63 1.81 0.51 2.03 0.54 ＜0.001
Hypertension (n,  %) 28 25.93 20 47.62 22 56.41 0.001
Diabetes (n,  %) 8 7.41 9 21.43 7 17.95 0.037
Hyperlipidemia (n,  %) 10 9.26 11 26.19 6 15.38 0.03
Hyperuricemia (n,  %) 10 9.26 5 11.90 5 12.82 0.788
Hyperparathyroidism (n,  %) 0 0 0 0 1 2.56 0.146
SD,  standard deviations; BMI,  body mass index; ASA,  the American Society of Anesthesiologists.
characteristics of the 3 groups.  There were signiﬁ-
cant diﬀerences among the 3 groups for the following 
parameters: Age (p＜0.001),  BMI (p＜0.001),  ASA 
score (p＜0.001),  and prevalence of hypertension (p
＝0.001),  diabetes (p＝0.037),  and hyperlipidemia (p
＝0.03).  Table 2 shows the results of the post hoc 
analysis among the variables that presented signiﬁcant 
diﬀerences.  Between the＜65 group and the 65-74 
group,  there was a signiﬁcant diﬀerence in age (p＜
0.001),  BMI (p＝0.027),  hypertension (p＝0.034) and 
hyperlipidemia (p＝0.023).  Between the＜65 group 
and the 75 group,  there was a signiﬁcant diﬀerence 
in age (p＜0.001),  BMI (p＜0.001),  ASA score (p＜
0.001),  and hypertension (p＝0.001).  Between the 
65-74 group and the 75 group,  there was a signiﬁ-
cant diﬀerence in age (p＜0.001).
　 The characteristics of the target stones and the 
results of the comparisons of perioperative factors are 
shown in Table 3.  There were no signiﬁcant between-
group diﬀerences in any of the parameters including 
postoperative pyelonephritis and SF status.  Only 
stone location diﬀered between the＜65 group and the 
65-74 group,  but the diﬀerence was not signiﬁcant (p
＝0.093) (data not shown).  There was only one case of 
ureteral injury (Clavien-Dindo grade 3),  in the＜65 
group.  However,  there were no other postoperative 
complications,  including thromboembolism,  cardiovas-
cular events,  or cerebrovascular events in any of the 
3 groups,  including the elderly and very elderly 
patients.
　 Table 4 shows the associations of perioperative 
variables (ASA score,  stone size,  diabetes,  and pre-
operative pyelonephritis) with postoperative pyelone-
phritis,  and Table 5 shows the associations (stone size 
and CT radiodensity) with SFR.  We performed a 
binominal logistic regression analysis referring to the
＜65 group.  In Table 4,  we found that the occurrence 
of preoperative pyelonephritis increased the OR of 
postoperative pyelonephritis (OR＝3.581,  p＝0.012).  
However,  there were no signiﬁcant diﬀerences in ORs 
in any of the models between the＜65 group and the 
65-74 group,  or between the＜65 group and the 75 
group.  As shown in Table 5,  the stone size signiﬁ-
cantly decreased the OR of SFR (OR＝0.87,  p＝
0.007).  There was a diﬀerence between the＜65 
group and the 65-74 group,  but it was not signiﬁcant 
(OR＝0.375,  p＝0.056).  Between the＜65 group and 
the 75 group,  there were no signiﬁcant diﬀerences.
Discussion
　 We retrospectively reviewed our registry of 252 
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Table 2　 Between-group comparisons of perioperative factors
x y Mean diﬀerence SE 95%CI p
Age ＜65 vs. 65-74 －18.18 1.61 －14.38 - －21.98 ＜0.001
vs. 75 －28.38 1.65 －24.48 - －32.28 ＜0.001
65-74 vs. 75 －10.20 1.97 －5.56 - －14.84 ＜0.001
BMI ＜65 vs. 65-74 2.04 0.78 3.89 - 0.19 0.027
vs. 75 3.26 0.81 5.18 - 1.34 ＜0.001
65-74 vs. 75 1.23 0.96 3.51 - －1.05 0.413
ASA score ＜65 vs. 65-74 －0.225 0.107 －0.48 - 0.03 0.092
vs. 75 －0.441 0.11 －0.7 - －0.18 ＜0.001
65-74 vs. 75 －0.216 0.13 －0.52 - 0.09 0.224
Diabetes ＜65 vs. 65-74 －0.14 0.06 －0.28 - 0 0.053
vs. 75 －0.105 0.062 －0.25 - 0.04 0.204
65-74 vs. 75 0.035 0.073 －0.14 - 0.21 0.883
Hypertension ＜65 vs. 65-74 －0.215 0.085 －0.42 - －0.01 0.034
vs. 75 －0.317 0.089 －0.53 - －0.11 0.001
65-74 vs. 75 －0.103 0.105 －0.35 - 0.15 0.591
Hyperlipidemia ＜65 vs. 65-74 －0.168 0.063 －0.32 - 0.02 0.023
vs. 75 －0.06 0.065 －0.21 - 0.09 0.622
65-74 vs. 75 0.108 0.077 －0.07 - 0.29 0.343
Mean diﬀerence equals the average of (x) － the average of (y).
SE,  standard errors; CI,  conﬁdence intervals.
patients who underwent URS lithotripsy.  The BMI,  
ASA score,  and prevalence of hypertension,  diabetes,  
and hyperlipidemia were signiﬁcantly higher in the 
elderly patients.  However,  SFR and perioperative 
adverse events were not signiﬁcantly between the 
younger and elderly patients.  Hence,  our data suggest 
that URS lithotripsy is a safe and eﬀective procedure 
even for elderly patients.
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Table 3　 Characteristics of stones and comparisons of descriptions
＜65 group 65-74 group 75 group
pn＝108 n＝42 n＝39
Mean SD Mean SD Mean SD
Laterality (n,  left : right) 54 : 54 23 : 19 18 : 21 0.738
Location (n,  %)
Upper calyx 2 1.85 0 0 1 2.56 0.731
Middle calyx 7 6.48 0 0 2 5.13
Lower calyx 3 2.78 1 2.38 0 0
UPJ 9 8.33 3 7.14 3 7.69
U1 35 32.41 13 30.95 15 38.46
U2 12 11.11 2 4.76 3 7.69
U3 14 12.96 9 21.43 8 20.51
Multiple 26 24.07 14 33.33 7 17.95
Stone size (mm) 9.47 4.55 9.56 3.27 8.80 3.16 0.622
Average CT radiodensity (HU) 963.96 351.36 981.08 367.27 910.03 345.54 0.631
Preoperative ureteral stent (n,  %) 32 29.63 11 26.19 15 38.46 0.462
Preoperative pyelonephritis (n, %) 16 14.81 7 16.67 11 28.21 0.172
Operative duration (minutes) 73.59 29.85 72.43 30.51 70.67 30.58 0.603
Postoperative pyelonephritis (n,  %) 12 11.11 5 11.90 5 12.82 0.959
Stone free status (n,  %) 97 89.81 33 78.57 36 92.31 0.106
Stone composition (n,  %) CaOx 73 67.59 24 57.14 18 46.15 0.051
UA 3 2.78 1 2.38 3 7.69
CaP 4 3.70 2 4.76 5 12.82
Mix/others 7 6.48 5 11.90 6 15.38
Unknown 21 19.44 10 23.81 7 17.95
SD,  standard deviation; UPJ,  ureteropelvic junction; CT,  computed tomography; HU,  Hounsﬁeld unit; CaOx,  calcium oxalate; UA,  uric 
acid; CaP,  calcium phosphate.
Table 4　 Odds ratios and 95% conﬁdence intervals for postoperative pyelonephritis
Model 1 Model 2 Model 3 Model 4
OR (95%CI) p OR (95%CI) p OR 95%CI p OR 95%CI p
Age
＜65 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
65-74 1.06 (0.35-3.21) 0.92 0.95 (0.31-2.9) 0.93 0.955 (0.31-2.94) 0.937 0.948 (0.30-3.01) 0.927
75 1.15 (0.38-3.51) 0.804 0.91 (0.29-2.90) 0.877 0.903 (0.28-2.88) 0.863 0.76 (0.23-2.57) 0.658
ASA score 1.76 (0.83-3.74) 0.14 1.757 (0.83-3.73) 0.142 1.475 (0.66-3.30) 0.344
Stone size (mm) 0.978 (0.87-1.10) 0.721 0.982 (0.87-1.11) 0.767




Model 1,  adjusted for age; model 2,  adjusted for age and ASA score; model 3,  adjusted for age,  ASA score and stone size; model 4,  
adjusted for age,  ASA score,  stone size,  diabetes and preoperative pyelonephritis.
OR,  odds ratio; CI,  conﬁdence intervals.
　 Upper urinary tract calculi are increasingly com-
mon among elderly patients [5,  6].  Although there are 
many interventions for upper urinary tract calculi,  
there are no standardized treatments for elderly 
patients.  In many cases,  SWL is preferable for upper 
urinary tract calculi.  Recent guidelines recommend 
that for all renal calculi except those in the lower pole,  
SWL is recommended for not only calculi that are＜
10mm but also those measuring 10-20mm.  SWL is 
also recommended for proximal ureter calculi,  even 
for calculi＞10mm [2,  3].  Salman et al.  showed that 
stone size and location are predictors of successful 
SWL.  Stone size＜8mm and location in the upper 
ureter are predictors of success.  Stones＞8mm and 
location in the middle ureter have signiﬁcantly lower 
success rates for SWL [7].  Al-Ansari et al.  indicated 
that in renal calculi cases,  the renal morphology,  
congenital anomalies,  stone size,  stone site,  and 
number of treated stones are prognostic factors that 
predict success rate of SWL [8].  Abdel-Khalek et al.  
reported that the patientsʼ age as well as stone size,  
location,  morphology,  and ingredients are predictors 
of successful SWL for renal calculi [9].  The recom-
mendation of extending URS lithotripsy means that all 
cases for which SWL is recommended can be treated 
with URS lithotripsy [2,  3,  10].
　 Moreno et al.  observed that the ASA score can be 
used for patients aged 60 years [11].  According to 
a study by Huisman et al.,  for onco-geriatric surgical 
patients,  the ASA score is a good predictor of the 
incidence of postoperative complications [12].  The 
Clinical Research Oﬃce of the Endourological Society 
and De la Rosette et al.  showed that the most frequent 
postoperative complication after URS is fever [1].  
Referring to these studies,  we applied ASA scores to 
the univariate analysis shown in Table 4.  In addition,  
Mandal et al.  indicated that patients with calculi 
＞10mm have a greater incidence of postoperative 
complications including febrile urinary tract infec-
tions [13].  In a study by Daels et al.,  the prevalence 
of hypertension and diabetes among urolithiasis 
patients increased with age,  and elderly patients were 
likely to develop postoperative complications if they 
had diabetes or cardiovascular disease or had under-
gone anticoagulation therapy [14].  In addition,  
Mitsuzuka et al.  found that preoperative pyelonephritis 
before URS was a risk factor for postoperative febrile 
UTI,  and thus these patients need careful manage-
ment [15].  In light of the ﬁndings of these studies,  
we used stone size and preoperative pyelonephritis in 
the multivariate analysis shown in Table 4.
　 Ito et al.  indicated that the predicting factors of SF 
status after ﬂexible ureteroscopy for renal calculi are 
stone volume,  the presence of lower pole calculi,  oper-
ator experience＞50 URS procedures,  stone number,  
and the presence of hydronephrosis [16].  The stone 
diameter,  length,  volumetric stone burden,  estimate 
stone location,  Hounsﬁeld unit,  and tissue rim sign 
were reported to signiﬁcantly aﬀect the SFR [17].  
Referring to those studies,  we used stone size in the 
present univariate analysis,  and CT radiodensity (HU) 
in the multivariate analysis shown in Table 5.
　 The above studies suggested that the incidence of 
postoperative complications in elderly patients (the 
65-74 group and the 75 group under our deﬁnitions) 
may be higher than that in young patients (our＜65 
group).  In fact,  many clinicians choose ureteral stent 
exchange or SWL for elderly patients because they 
have more preoperative risk factors or a lower perfor-
mance status.  In our study,  we performed URS in 
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Table 5　 Odds ratios and 95% conﬁdence intervals for the stone-free rate (SFR)
Model 1 Model 2 Model 3
OR (95%CI) p OR (95%CI) p OR 95%CI p
Age
＜65 1 (Reference) 1 (Reference) 1 (Reference)
65-74 0.42 (0.16-1.09) 0.075 0.37 (0.14-1.02) 0.054 0.375 (0.14-1.03) 0.056
75 1.36 (0.36-5.16) 0.65 1.13 (0.29-4.48) 0.86 1.1 (0.28-4.36) 0.892
Stone size (mm) 0.86 (0.78-0.95) 0.003 0.87 (0.79-0.96) 0.007
CT radiodensity (HU) 1 (0.998-1.001) 0.611
Model 1,  adjusted for age; model 2,  adjusted for age and stone size; model 3,  adjusted for age,  stone size and CT radiodensity.
CT,  computed tomography; OR,  odds ratio; CI,  conﬁdence intervals.
patients for whom URS lithotripsy is preferred over 
SWL,  and we retrospectively evaluated the surgical 
outcomes of the URS lithotripsy after dividing the 189 
cases into 3 age groups.  The elderly and very elderly 
patients (the 65-74 group and 75 group) had signiﬁ-
cantly higher incidences of preoperative complications 
and higher ASA scores than the patients in the＜65 
group.  In addition,  our elderly patients had higher 
incidences of preoperative pyelonephritis,  which is a 
risk factor for postoperative pyelonephritis.  However,  
the incidences of postoperative pyelonephritis among 
the 3 groups were similar,  and were comparable to 
those reported in previous studies,  at 6-18  [13,  
15,  18].  No other complications except for one ure-
teral injury (1 out of 108 cases,  0.93 ) occurred.  The 
reported rates of ureteral injuries following URS 
lithotripsy are 0-4  [13,  18,  19],  which are similar 
to our ﬁnding.  These results support the proposition 
that URS lithotripsy can be performed safely even for 
elderly patients.
　 Approximately 50  of our elderly patients (65-74 
and 75 years old) had stones in the lower calyx or 
distal ureter,  or multiple calculi.  The URS litho-
tripsy had a higher SFR than SWL in those cases [2,  
3,  20,  21].  The SFR and stone characteristics were 
similar among the 3 groups in our study,  and the val-
ues are comparable to those of the previous studies 
[1,  21].  For example,  the SFR of our＜65 group 
was high,  at 89.81 .  This suggests that URS litho-
tripsy can provide a similar SF status regardless of 
age.  URS lithotripsy may be more eﬀective for treat-
ing upper urinary tract calculi in elderly patients than 
other treatment options.
　 The limitations of our study are that it was a ret-
rospective,  observational study at a single institute 
and that a relatively short follow-up period can evalu-
ate neither the long-term recurrence rate of stones nor 
the symptom-free and disease-free survival.  Despite 
these limitations,  our study suggests that URS litho-
tripsy may be a standard treatment for upper urinary 
tract calculi in elderly patients,  including very elderly 
patients aged 75 years or more.
　 In conclusion,  URS lithotripsy has a similar inci-
dence of postoperative pyelonephritis and similar SFR 
in young patients who are less than 65 years of age,  
and thus URS lithotripsy is one of the best treatments 
for upper urinary tract calculi even in elderly patients.
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